Biovision World Life Science Forum 2017

Biovision World Life Science Forum 20174 - 6 April 2017, Lyon, France.
Biovision World Life Science Forum is fostering a unique approach to meet, connect and collaborate between international decision-makers from the academic, civil society, policy-making and private sectors whether industrials or investors. Biovision being the place to network and make the connections you need to secure partnerships, investments and contacts.

Presenting an impressive line-up of participants addressing evidence and research as well as development and promotion, the 2017 edition of the Biovision life sciences forum affirms its status as a standout gathering of knowledge among other such international meetings. This year, the forum will welcome major players from the health sector representing each step of the value chain (research, innovation, partnerships and finance) with the goal of arriving at concrete solutions to existing and future health issues.

Biovision Prospective: A meeting place for stakeholders in global health
The Prospective meetings will facilitate discussions between Biovision participants, international experts and leading figures in global health and prevention throughout the course of four main session focusing on the following paths:

  • Global medical education & training
  • Digital health and innovation for sustainable healthcare
  • Emerging viral diseases
  • Animal health
  • Cancer
  • Innovative technologies and science of metagenomics to reach ONE HEALTH

During each session, twenty to thirty experts will participate and exchange ideas in workshops. Their conclusions will be presented at plenary session and finalized within the Call for action addressed to the international community at Biovision's closing ceremony.

Biovision Catalyzer: A springboard for innovative health projects and start-ups
Innovators in the fields of Biotech, Medtech and e-health may hold the solutions to the health issues of today and tomorrow. Biovision is committed to discovering these individuals, supporting them by putting their ideas in the spotlight, and placing them on the fast track towards the fulfilment and realisation of their work. During the Catalyzer meetings, these pioneers in emerging health fields will have the opportunity to pitch their proposals to an expert committee comprised of academic, industry and civil society partners for the chance to develop future collaborations as well as further implementation of their projects.

Innovators will also be more than welcome to take part in Biovision Prospective paths, to challenge, exchange and discuss with Key Opinion Leaders (KOLs) and experts, participate in the ensuing Insight sessions that will lead to Call for Actions on major health issues. They will also get to meet and exchange with KOLs during 'Coffee with' sessions.

Biovision Investor: The intersection of health start-ups and venture capital
The INVESTOR accelerates the fundraising process of Biotech, Medtech and e-health start-ups by putting them in direct contact with potential business and development partners. Selected from a pool of applicants by a special committee, start-ups with the greatest potential to offer innovative health solutions will present their pitches during the Biovision forum in front of a jury comprised of leading European private and corporate investors in the life sciences.

For furher information, please visit:
http://www.biovision.org

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...